Atossa Therapeutics
ATOS
#10050
Rank
โ‚น4.00 B
Marketcap
โ‚น465.56
Share price
2.00%
Change (1 day)
478.59%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น24.05. In 2024 the company made an earnings per share (EPS) of -โ‚น19.24 an increase over its 2023 EPS that were of -โ‚น23.09.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5211.87%
2024-โ‚น19.24-16.67%
2023-โ‚น23.0914.29%
2022-โ‚น20.2016.67%
2021-โ‚น17.31-90.86%
2020-โ‚น189.49-2.96%
2019-โ‚น195.27-63.09%
2018-โ‚น529.05-49.63%
2017-โ‚น1,050-57.87%
2016-โ‚น2,493-74.01%
2015-โ‚น9,592-9.18%
2014-โ‚น10,562-12.86%
2013-โ‚น12,12070.73%
2012-โ‚น7,09934.08%
2011-โ‚น5,295263.47%
2010-โ‚น1,457

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น840.35-3,594.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น882.06-3,768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,093-4,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น59.64 148.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น20.20-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA